Group One Trading’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $153K | Buy |
18,200
+1,500
| +9% | +$15.8K | ﹤0.01% | 4347 |
|
|
2025
Q4 | $240K | Buy |
16,700
+10,400
| +165% | +$130K | ﹤0.01% | 4212 |
|
|
2025
Q3 | $60.8K | Sell |
6,300
-8,100
| -56% | -$71.6K | ﹤0.01% | 5787 |
|
|
2025
Q2 | $118K | Buy |
14,400
+9,700
| +206% | +$81.2K | ﹤0.01% | 4830 |
|
|
2025
Q1 | $33.6K | Sell |
4,700
-64,900
| -93% | -$483K | ﹤0.01% | 5469 |
|
|
2024
Q4 | $538K | Buy |
69,600
+34,700
| +99% | +$326K | ﹤0.01% | 3107 |
|
|
2024
Q3 | $366K | Buy |
34,900
+34,400
| +6,880% | +$419K | ﹤0.01% | 3091 |
|
|
2024
Q2 | $5.85K | Sell |
500
-7,000
| -93% | -$109K | ﹤0.01% | 5884 |
|
|
2024
Q1 | $158K | Sell |
7,500
-2,000
| -21% | -$35.6K | ﹤0.01% | 3756 |
|
|
2023
Q4 | $171K | Buy |
9,500
+1,200
| +14% | +$21.1K | ﹤0.01% | 4004 |
|
|
2023
Q3 | $137K | Sell |
8,300
-16,300
| -66% | -$295K | ﹤0.01% | 4146 |
|
|
2023
Q2 | $492K | Buy |
24,600
+18,000
| +273% | +$347K | ﹤0.01% | 3040 |
|
|
2023
Q1 | $125K | Sell |
6,600
-500
| -7% | -$11.1K | ﹤0.01% | 4100 |
|
|
2022
Q4 | $161K | Hold |
7,100
| – | – | ﹤0.01% | 4037 |
|
|
2022
Q3 | $188K | Buy |
7,100
+5,500
| +344% | +$163K | ﹤0.01% | 4206 |
|
|
2022
Q2 | $40K | Sell |
1,600
-6,400
| -80% | -$160K | ﹤0.01% | 5753 |
|
|
2022
Q1 | $266K | Sell |
8,000
-2,800
| -26% | -$77.8K | ﹤0.01% | 4499 |
|
|
2021
Q4 | $353K | Buy |
10,800
+1,900
| +21% | +$64.7K | ﹤0.01% | 4504 |
|
|
2021
Q3 | $373K | Buy |
8,900
+5,000
| +128% | +$180K | ﹤0.01% | 4517 |
|
|
2021
Q2 | $152K | Sell |
3,900
-2,100
| -35% | -$75.1K | ﹤0.01% | 5522 |
|
|
2021
Q1 | $205K | Buy |
6,000
+1,000
| +20% | +$42.6K | ﹤0.01% | 5003 |
|
|
2020
Q4 | $227K | Buy |
5,000
+3,700
| +285% | +$129K | ﹤0.01% | 3968 |
|
|
2020
Q3 | $36K | Sell |
1,300
-100
| -7% | -$3.26K | ﹤0.01% | 4842 |
|
|
2020
Q2 | $52K | Buy |
1,400
+1,000
| +250% | +$37.3K | ﹤0.01% | 4335 |
|
|
2020
Q1 | $13K | Sell |
400
-5,200
| -93% | -$217K | ﹤0.01% | 4464 |
|
|
2019
Q4 | $229K | Buy |
5,600
+3,200
| +133% | +$126K | ﹤0.01% | 3081 |
|
|
2019
Q3 | $85K | Buy |
2,400
+300
| +14% | +$12.2K | ﹤0.01% | 3662 |
|
|
2019
Q2 | $108K | Buy |
2,100
+1,800
| +600% | +$89.9K | ﹤0.01% | 3295 |
|
|
2019
Q1 | $17K | Sell |
300
-5,500
| -95% | -$272K | ﹤0.01% | 4086 |
|
|
2018
Q4 | $243K | Buy |
5,800
+900
| +18% | +$52.8K | ﹤0.01% | 2528 |
|
|
2018
Q3 | $370K | Buy |
4,900
+4,100
| +513% | +$295K | ﹤0.01% | 2533 |
|
|
2018
Q2 | $57K | Buy |
800
+500
| +167% | +$23.9K | ﹤0.01% | 3876 |
|
|
2018
Q1 | $9K | Buy |
+300
| New | +$8.73K | ﹤0.01% | 4355 |
|
Other funds holding RGNX
RG
VCM
IHAM
Group One Trading's RGNX Position: Q1 2026 in Review
Group One Trading increased its Regenxbio (RGNX) stake by 109% in Q1 2026, buying an estimated $9.18K and bringing the position to 1,678 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6163.
Group One Trading first reported a position in RGNX in Q4 2017 and has held it in 22 quarters since. The position peaked at $2.06M in Q2 2019. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Group One Trading held 1,678 shares of Regenxbio worth $14.1K as of Q1 2026.
- Group One Trading bought 874 Regenxbio shares in Q1 2026, an estimated $9.18K.
- Regenxbio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6163 holding.
- Group One Trading first reported a position in Regenxbio in Q4 2017 and has held it in 22 quarters since.
- Group One Trading's Regenxbio position peaked at $2.06M in Q2 2019.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.